Top Industry Leaders in the Xanthoma Market
Latest Xanthoma Companies Updates:
A June 2023 study in the Journal of Clinical Lipidology explored the effectiveness of various treatments for xanthomas associated with familial hypercholesterolemia.An August 2023 article in The American Journal of Dermatopathology discussed the diagnostic features of different types of xanthoma.
AstraZeneca and Sanofi have ongoing development programs for cholesterol-lowering medications and treatments for conditions linked to xanthoma. These advancements could indirectly impact future xanthoma management.
List of Xanthoma Key companies in the market:
- Teva Pharmaceutical Industries
- AstraZeneca PLC
- Sanofi
- Bayer HealthCare Pharmaceuticals LLC
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline PLC
- Novo Nordisk
- Novartis International AG